The EU-funded HORIZON project siNPAIN held its final consortium meeting this week in Bordeaux, France, kindly hosted by BIOTIS Bordeaux. Project partners came together for a comprehensive review of the project’s achievements, key outcomes, and final activities, marking an important milestone as the consortium approaches the end of this innovative initiative.
ASPHALION, as the regulatory partner and leader of Work Package 6 (WP6), presented the final results and achievements of WP6, highlighting the regulatory strategy developed throughout the project and the main outcomes delivered to support the future development of the siNPAIN therapy. Our experts Nuria Coderch and Joan Cabellos represented ASPHALION and shared the final WP6 conclusions with the consortium, while all partners presented the final results of their respective work packages.
Asphalion would also like to express its sincere thanks to all siNPAIN partners, for their dedication, expertise, and collaborative spirit throughout the entire EU-funded project. Their joint efforts have been instrumental in driving this work forward.
Need help with your EU-funded projects? Contact us at: [email protected]
